POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study
POLB 001（一种 p38 MAPK 抑制剂）可降低健康志愿者体内注射 LPS 后引起的局部和全身炎症反应：一项随机、双盲、安慰剂对照研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1684307
de Bruin, Digna T; Jansen, Manon A A; Pereira, Diana R; van Schijndel, Lisa; Klaassen, Erica S; Otto, Marije E; Skillington, Jeremy; Maguire, Paula; Tremble, Liam; Bell, Alan; Maher, Laura; Mihara, Katsuhiro; Sumeray, Mark; Gilroy, Derek W; Klarenbeek, Naomi B; Moerland, Matthijs
